Strain
|
Amount n [µmol]
|
---|
2a
|
3a
|
3b
|
2A (AM)
c
|
3A (1a + AM)
c
|
---|
0.019
|
0.1
|
0.19
|
0.019
|
0.1
|
0.19
|
0.019
|
0.1
|
0.19
|
0.019
|
0.1
|
0.19
|
0.019
|
0.1
|
0.19
|
---|
Staphylococcus aureus ATCC 6538
|
ra
|
r
|
r
|
12b
|
18
|
22
|
r
|
24
|
30
|
36
|
42
|
44
|
26
|
30
|
34
|
S. aureus Norddeutscher Stamm
|
r
|
r
|
r
|
r
|
16
|
18
|
r
|
r
|
16
|
r
|
12
|
14
|
r
|
10
|
14
|
S. aureus 315
|
r
|
r
|
r
|
r
|
r
|
r
|
r
|
r
|
r
|
8
|
14
|
16
|
r
|
8
|
12
|
S. epidermidis 99,847
|
r
|
r
|
r
|
r
|
r
|
r
|
r
|
r
|
r
|
20
|
24
|
26
|
14
|
20
|
22
|
Strain
|
Amount n [µmol]
|
---|
2b
|
3c
|
3d
|
2B (CD)
d
|
3B (1a + CD)
d
|
---|
0.019
|
0.1
|
0.19
|
0.019
|
0.1
|
0.19
|
0.019
|
0.1
|
0.19
|
0.019
|
0.1
|
0.19
|
0.019
|
0.1
|
0.19
|
---|
S. aureus ATCC 6538
|
r
|
r
|
r
|
r
|
14
|
18
|
r
|
r
|
10
|
32
|
38
|
40
|
20
|
28
|
30
|
S. aureus Norddeutscher Stamm
|
r
|
r
|
r
|
r
|
20
|
24
|
r
|
r
|
r
|
r
|
r
|
10
|
r
|
16
|
18
|
S. aureus 315
|
r
|
r
|
r
|
r
|
r
|
r
|
r
|
r
|
r
|
r
|
r
|
8
|
r
|
10
|
16
|
S. epidermidis 99,847
|
r
|
r
|
r
|
r
|
r
|
22
|
r
|
r
|
14
|
20
|
24
|
26
|
r
|
10
|
16
|
Strain
|
Amount n [µmol]
|
---|
2c
|
3e
|
3f
|
2B (CD)
d
|
3C (1b + CD)
d
|
---|
0.019
|
0.1
|
0.19
|
0.019
|
0.1
|
0.19
|
0.019
|
0.1
|
0.19
|
0.019
|
0.1
|
0.19
|
0.019
|
0.1
|
0.19
|
---|
S. aureus ATCC 6538
|
r
|
r
|
r
|
r
|
18
|
22
|
r
|
14
|
30
|
32
|
38
|
40
|
18
|
26
|
30
|
S. aureus Norddeutscher Stamm
|
r
|
r
|
r
|
r
|
20
|
22
|
r
|
r
|
r
|
r
|
r
|
10
|
r
|
10
|
14
|
S. aureus 315
|
r
|
r
|
r
|
r
|
r
|
r
|
r
|
r
|
r
|
r
|
r
|
8
|
r
|
r
|
12
|
S. epidermidis 99,847
|
r
|
r
|
r
|
r
|
r
|
24
|
r
|
r
|
r
|
20
|
24
|
26
|
r
|
14
|
20
|
- a Resistant (no zone of inhibition)
- b Zones of inhibition (mm)
- c Educt 2A and product 3A are described previously (Mikolasch et al. 2006); AM amoxicillin
- d Educt 2B and products 3B, 3C are described previously (Mikolasch et al. 2007); CD cefadroxil